The Role of Artificial Intelligence in the Modern R&D Lab
Thomas Swalla, CEO of Dotmatics, explains how artificial intelligence integrated into Dotmatics' software platform helps modern R&D labs by automating data analysis, breaking down data silos, reducing research costs, and accelerating the discovery of medical therapies.
Watch Thomas Swalla, CEO of Dotmatics, discuss the role of artificial intelligence in R&D labs.
Scientists generate a tremendous amount of data as they conduct experiments to test and identify medical therapies. In an effort to optimize and speed up research, artificial intelligence helps scientists to contextualize and understand the large amounts of data they generate, which is traditionally siloed between teams and handled manually. By automating processes and incorporating AI, costs for finding cures can be driven down so researchers can uncover therapies that were formerly too expensive to tackle.
Artificial intelligence is part of Dotmatics' software model, which accelerates discoveries by connecting research data sources onto a single platform. Learn more about how AI is enabling the solution.
Related
Scripps News America Tonight
Phil Mounteney, VP of Science and Technology at Dotmatics, explains in Scripps News America Tonight how Dotmatics Luma uses AI to transform scientific research and pharmaceutical drug discovery by accelerating innovation, lowering costs, and shortening time-to-market for modern laboratories.
The Future of AI in Drug Discovery
The Forbes article discusses how AI is revolutionizing drug discovery by accelerating R&D and improving decision-making, highlighting Dotmatics’ role in integrating data and applying AI to scientific workflows, while also connecting these advancements to broader innovations in sustainability and global problem-solving.
NBC News: How AI is Transforming Drug Discovery
In an NBC News segment, Alister Campbell, VP of Dotmatics, explains how the company leverages AI to analyze large datasets, predict effective drug compounds, and streamline fragmented data systems and manual workflows, thereby accelerating and improving the efficiency of drug discovery.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
ABC News: How AI is Transforming Drug Discovery
Christian Olsen, VP of Biologics at Dotmatics, explains in an ABC News interview how AI is transforming pharmaceutical R&D by accelerating drug target identification and high-throughput screening, thereby significantly reducing the time and cost of drug discovery and enabling breakthroughs in diseases like cancer, diabetes, cardiovascular conditions, and neurology.
How AI is Transforming Drug Discovery
Dotmatics executives Kalim Saliba and Steve Tharp explain in an NBC News Boston feature how AI is revolutionizing drug discovery by enabling researchers to navigate complex data more efficiently, significantly reducing development time and costs, and accelerating the creation of safer, personalized medicines.